# Venrock

> Venrock is a VC fund in Palo Alto backing Health Care and Biotechnology. See 530 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Palo Alto, United States
- Total investments: 530
- Last investment: Aug 2026
- Lead investor: 27%
- Fund size: $550M
- Last fund: Jan 2004
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/company/venrock
- X (Twitter): http://twitter.com/Venrock
- Website: http://www.venrock.com
- Facebook: http://www.facebook.com/venrock

Venrock is a VC fund in Palo Alto focused on Health Care and Biotechnology. Venrock continues a tradition of partnering with entrepreneurs to establish successful, enduring companies. With a primary focus on technology and healthcare, portfolio companies have included Apple Computer, Athenahealth, Centocor, Check Point Software, DoubleClick, Endeca, Gilead Sciences, Idec Pharma, Imperva, Illumina, Intel, Nest, SlideShare,and Tudou.

## Contacts

5 contacts available for Venrock. Shizune tracks 16 team members at Venrock. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/venrock?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $3.5M–$50M |
| Series B | $8M–$66M |
| Series C | $11M–$100M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 81 | 15% |
| Biotechnology | 74 | 14% |
| Software | 52 | 10% |
| Medical | 39 | 7% |
| Information Technology | 30 | 6% |

214 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 107 | 20% |
| Series A | 95 | 18% |
| Series C | 83 | 16% |
| Series D | 50 | 9% |
| Funding Round | 47 | 9% |

13 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 254 | 48% |
| Canada | 3 | 1% |
| Switzerland | 3 | 1% |
| United Kingdom | 3 | 1% |
| China | 2 | 0% |

7 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Andrew Gottesdiener | Partner | 3 | https://shizune.co/investors/profile/andrew-gottesdiener-91c0 |
| Anthony Evnin | Partner Emeritus | 17 | https://shizune.co/investors/profile/anthony-evnin |
| Bryan Roberts | Partner | 44 | https://shizune.co/investors/profile/bryan-e-roberts |
| Mariana Mihalusova | Vice President | 3 | https://shizune.co/investors/profile/mariana-mihalusova-65b2 |
| Mike Tyrrell | General Partner | 24 | https://shizune.co/investors/profile/mike-tyrrell |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Expedition Therapeutics | Expedition Therapeutics operates as an unincorporated association. | $115M | Series B | Aug 05, 2026 |  |
| Arca Wealth | Arca is an AI-native wealth management firm that pairs human financial advisors with purpose-built AI agents to deliver highly personalized, scalable advice for high-net-worth and growing clients. The company runs an integrated platform that automates operational work | $48.5M | Series A | Jun 25, 2026 |  |
| cAMPfield Therapeutics | cAMPfield Therapeutics is a biotechnology company that specializes on exploration and development activities of therapeutic solutions. | $180M | Series A | May 20, 2026 |  |
| GenLogs | GenLogs is a freight intelligence company that offers truck carrier mapping services via AI-driven roadside sensors. | $60M | Series B | Feb 02, 2026 |  |
| FINNY | FINNY is an AI prospecting tool that provides technology solutions for financial advisors. | $17M | Series A | Dec 18, 2025 |  |
| Archetype AI | Archetype AI is a group of designers and technologists they are pioneering revolutionary artificial intelligence and interaction technologies for the real world. | $35M | Series A | Nov 20, 2025 |  |
| Archetype AI | Archetype AI is a group of designers and technologists they are pioneering revolutionary artificial intelligence and interaction technologies for the real world. | $35M | Series A | Nov 20, 2025 |  |
| Syllo | Syllo is a legal technology platform | $30M | Venture - Series Unknown | Oct 28, 2025 |  |
| Expedition Therapeutics | Expedition Therapeutics operates as an unincorporated association. | $165M | Series A | Oct 09, 2025 |  |
| Euclid Power | Euclid Power operates in the renewable energy sector, providing a comprehensive platform for project management, investment, and execution. The company offers data-driven solutions that span from project development to asset management. Euclid Power's platform is designed to simplify the process of renewable energy project development andexecution. | $20M | Series A | Sep 05, 2025 |  |

10 of 530 investments shown.

## Co-investors
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund, 38 deals together
- [U.S. Venture Partners](https://shizune.co/investors/profile/us-venture-partners) — VC Fund, 27 deals together
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund, 21 deals together
- [Oak Investment Partners](https://shizune.co/investors/profile/oak-investment-partners) — VC Fund, 20 deals together
- [RA Capital Management](https://shizune.co/investors/profile/ra-capital-management) — VC Fund, 20 deals together
- [Foresite Capital](https://shizune.co/investors/profile/foresite-capital) — VC Fund, 18 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Breakthrough Energy Ventures](https://shizune.co/investors/profile/breakthrough-energy-ventures) — VC Fund
- [Shell Ventures](https://shizune.co/investors/profile/shell-technology-ventures) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Hardware VC Funds in United States](https://shizune.co/investors/hardware-vc-funds-united-states)
- [Hardware Investors in United States](https://shizune.co/investors/hardware-investors-united-states)
- [Medical Investors](https://shizune.co/investors/medical-investors)
- [Medical VC Funds](https://shizune.co/investors/medical-vc-funds)
- [Medical VC Funds in United States](https://shizune.co/investors/medical-vc-funds-united-states)
- [Infrastructure Investors](https://shizune.co/investors/infrastructure-investors)

## FAQ

### What does Venrock invest in?

Venrock invests primarily in Health Care, Biotechnology and Software startups, most often at Series B and Series A stage. Most of the 530 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Venrock's check size?

Venrock typically joins rounds of $3.5M–$50M at Series A, $8M–$66M at Series B and $11M–$100M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Venrock participates in.

### How do I contact Venrock?

Public channels for Venrock include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Venrock?

The team at Venrock includes Andrew Gottesdiener (Partner), Anthony Evnin (Partner Emeritus) and Bryan Roberts (Partner), among 16 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co